-
Sector Analysis
Small Cell Lung Cancer - Epidemiology Forecast to 2029
SCLC accounts for 15% of all lung cancers. SCLC is an aggressive form of lung cancer where approximately 60-70% of patients already have distant metastasis at presentation. SCLC is predominant in elderly populations that are heavy smokers, and the risk of SCLC is proportional to duration and frequency of smoking. Signs and symptoms of SCLC include cough, chest pain, hemoptysis, dyspnea, and weight loss. SCLC has a very poor survival rate, as most of the deaths occur within a year...
-
Product Insights
Oropharyngeal Cancer - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Oropharyngeal Cancer - Global Clinical Trials Review, H2, 2021" provides an overview of Oropharyngeal Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Oropharyngeal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
-
Product Insights
Medulloblastoma - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Medulloblastoma - Global Clinical Trials Review, H2, 2021" provides an overview of Medulloblastoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Medulloblastoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for...
-
Product Insights
Oligodendroglioma - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Oligodendroglioma - Global Clinical Trials Review, H2, 2021" provides an overview of Oligodendroglioma Clinical trials scenario. This report provides top line data relating to the clinical trials on Oligodendroglioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for...
-
Product Insights
Muscle Invasive Bladder Cancer (MIBC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Muscle Invasive Bladder Cancer (MIBC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Muscle Invasive Bladder Cancer (MIBC) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Muscle Invasive Bladder Cancer (MIBC), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research...
-
Product Insights
Meningioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Meningioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Meningioma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Meningioma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report...
-
Product Insights
Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Hormone Sensitive Breast Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hormone Sensitive Breast Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Product Insights
Myxoid Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Myxoid Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Myxoid Liposarcoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myxoid Liposarcoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Pleomorphic Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Pleomorphic Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Pleomorphic Liposarcoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pleomorphic Liposarcoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Androgen-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Androgen-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Androgen-Sensitive Prostate Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Androgen-Sensitive Prostate Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.